122 related articles for article (PubMed ID: 36967033)
41. Coumestrol promotes proliferation and osteoblastic differentiation in rat bone marrow stromal cells.
Wu XT; Wang B; Wei JN
J Biomed Mater Res B Appl Biomater; 2009 Aug; 90(2):621-8. PubMed ID: 19165772
[TBL] [Abstract][Full Text] [Related]
42. The adverse effect of phytoestrogens on the synthesis and secretion of ovarian oxytocin in cattle.
Mlynarczuk J; Wrobel MH; Kotwica J
Reprod Domest Anim; 2011 Feb; 46(1):21-8. PubMed ID: 19799752
[TBL] [Abstract][Full Text] [Related]
43. Inhibition of RANKL blocks skeletal tumor progression and improves survival in a mouse model of breast cancer bone metastasis.
Canon JR; Roudier M; Bryant R; Morony S; Stolina M; Kostenuik PJ; Dougall WC
Clin Exp Metastasis; 2008; 25(2):119-29. PubMed ID: 18064531
[TBL] [Abstract][Full Text] [Related]
44. Phytoestrogen modulation of bone-related cytokines and its impact on cell viability in human prostate cancer cells.
Alonso V; Pérez-Martínez FC; Calahorra FJ; Esbrit P
Life Sci; 2009 Sep; 85(11-12):421-30. PubMed ID: 19632246
[TBL] [Abstract][Full Text] [Related]
45. Plumbagin inhibits osteoclastogenesis and reduces human breast cancer-induced osteolytic bone metastasis in mice through suppression of RANKL signaling.
Sung B; Oyajobi B; Aggarwal BB
Mol Cancer Ther; 2012 Feb; 11(2):350-9. PubMed ID: 22090419
[TBL] [Abstract][Full Text] [Related]
46. Phytoestrogens regulate the expression of genes involved in different biological processes in BRCA2 knocked down MCF-7, MDA-MB-231 and MCF-10a cell lines.
Bernard-Gallon DJ; Satih S; Chalabi N; Rabiau N; Bosviel R; Fontana L; Bignon YJ
Oncol Rep; 2010 Mar; 23(3):647-53. PubMed ID: 20127002
[TBL] [Abstract][Full Text] [Related]
47. Pharmacological Inhibition of the Skeletal IKKβ Reduces Breast Cancer-Induced Osteolysis.
Marino S; Bishop RT; Mollat P; Idris AI
Calcif Tissue Int; 2018 Aug; 103(2):206-216. PubMed ID: 29455416
[TBL] [Abstract][Full Text] [Related]
48. Effects of phytoestrogens and environmental estrogens on osteoblastic differentiation in MC3T3-E1 cells.
Kanno S; Hirano S; Kayama F
Toxicology; 2004 Mar; 196(1-2):137-45. PubMed ID: 15036763
[TBL] [Abstract][Full Text] [Related]
49. The influence of coumestrol, zearalenone, and genistein administration on insulin receptors and insulin secretion in ovariectomized rats.
Nogowski L; Nowak KW; Kaczmarek P; Maćkowiak P
J Recept Signal Transduct Res; 2002; 22(1-4):449-57. PubMed ID: 12503633
[TBL] [Abstract][Full Text] [Related]
50. Dietary phytoestrogens are not associated with risk of overall breast cancer but diets rich in coumestrol are inversely associated with risk of estrogen receptor and progesterone receptor negative breast tumors in Swedish women.
Hedelin M; Löf M; Olsson M; Adlercreutz H; Sandin S; Weiderpass E
J Nutr; 2008 May; 138(5):938-45. PubMed ID: 18424605
[TBL] [Abstract][Full Text] [Related]
51. Delayed activation of extracellular-signal-regulated kinase 1/2 is involved in genistein- and equol-induced cell proliferation and estrogen-receptor-alpha-mediated transcription in MCF-7 breast cancer cells.
Liu H; Du J; Hu C; Qi H; Wang X; Wang S; Liu Q; Li Z
J Nutr Biochem; 2010 May; 21(5):390-6. PubMed ID: 19427779
[TBL] [Abstract][Full Text] [Related]
52. Knockdown of Bone Morphogenetic Proteins Type 1a Receptor (BMPR1a) in Breast Cancer Cells Protects Bone from Breast Cancer-Induced Osteolysis by Suppressing RANKL Expression.
Liu Y; Zhang RX; Yuan W; Chen HQ; Tian DD; Li H; Jiang X; Deng ZL; Wang Y
Cell Physiol Biochem; 2018; 45(5):1759-1771. PubMed ID: 29495003
[TBL] [Abstract][Full Text] [Related]
53. Influence of phytoestrogens on the proliferation and expression of adhesion receptors in human mammary epithelial cells in vitro.
Nebe B; Peters A; Duske K; Richter DU; Briese V
Eur J Cancer Prev; 2006 Oct; 15(5):405-15. PubMed ID: 16912569
[TBL] [Abstract][Full Text] [Related]
54. Betulinic acid, a bioactive pentacyclic triterpenoid, inhibits skeletal-related events induced by breast cancer bone metastases and treatment.
Park SY; Kim HJ; Kim KR; Lee SK; Lee CK; Park KK; Chung WY
Toxicol Appl Pharmacol; 2014 Mar; 275(2):152-62. PubMed ID: 24463094
[TBL] [Abstract][Full Text] [Related]
55. Impact of lower concentrations of phytoestrogens on the effects of estradiol in breast cancer cells.
Chen FP; Chien MH; Chern IY
Climacteric; 2015; 18(4):574-81. PubMed ID: 25581323
[TBL] [Abstract][Full Text] [Related]
56. Phytoestrogens and breast cancer: a complex story.
Helferich WG; Andrade JE; Hoagland MS
Inflammopharmacology; 2008 Oct; 16(5):219-26. PubMed ID: 18815740
[TBL] [Abstract][Full Text] [Related]
57. Metabolic profiling reveals sphingosine-1-phosphate kinase 2 and lyase as key targets of (phyto-) estrogen action in the breast cancer cell line MCF-7 and not in MCF-12A.
Engel N; Lisec J; Piechulla B; Nebe B
PLoS One; 2012; 7(10):e47833. PubMed ID: 23112854
[TBL] [Abstract][Full Text] [Related]
58. Asperolide A prevents bone metastatic breast cancer via the PI3K/AKT/mTOR/c-Fos/NFATc1 signaling pathway.
Jiang W; Rixiati Y; Huang H; Shi Y; Huang C; Jiao B
Cancer Med; 2020 Nov; 9(21):8173-8185. PubMed ID: 32976685
[TBL] [Abstract][Full Text] [Related]
59. Calycosin and genistein induce apoptosis by inactivation of HOTAIR/p-Akt signaling pathway in human breast cancer MCF-7 cells.
Chen J; Lin C; Yong W; Ye Y; Huang Z
Cell Physiol Biochem; 2015; 35(2):722-8. PubMed ID: 25613518
[TBL] [Abstract][Full Text] [Related]
60. Assessment of the potential activity of major dietary compounds as selective estrogen receptor modulators in two distinct cell models for proliferation and differentiation.
Lecomte S; Lelong M; Bourgine G; Efstathiou T; Saligaut C; Pakdel F
Toxicol Appl Pharmacol; 2017 Jun; 325():61-70. PubMed ID: 28396216
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
